Article
Standardization of zebrafish drug testing parameters for muscle diseases
1 Jan 2024
Abstract excerpt
Skeletal muscular diseases predominantly affect skeletal and cardiac muscle, resulting in muscle weakness, impaired respiratory function and decreased lifespan. These harmful outcomes lead to poor health-related quality of life and carry a high healthcare economic burden. The absence of promising treatments and new therapies for muscular disorders requires new methods for candidate drug identification and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
